Filomena Fezza

10.5k total citations · 3 hit papers
80 papers, 7.8k citations indexed

About

Filomena Fezza is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Filomena Fezza has authored 80 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pharmacology, 31 papers in Cellular and Molecular Neuroscience and 15 papers in Surgery. Recurrent topics in Filomena Fezza's work include Cannabis and Cannabinoid Research (73 papers), Neuroscience and Neuropharmacology Research (22 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Filomena Fezza is often cited by papers focused on Cannabis and Cannabinoid Research (73 papers), Neuroscience and Neuropharmacology Research (22 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Filomena Fezza collaborates with scholars based in Italy, United States and Spain. Filomena Fezza's co-authors include Vincenzo Di Marzo, Mauro Maccarrone, Tiziana Bisogno, Monica Bari, Claire Williams, Tim C. Kirkham, Luciano De Petrocellis, Valeria Gasperi, George Kunos and Zoltán Járai and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Filomena Fezza

79 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin-regulated endocannabinoids are involved in maintaining food intake

2001 1.3k citations Vincenzo Di Marzo, Filomena Fezza et al. profile →
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

2002 723 citations Tiziana Bisogno, Luciano De Petrocellis et al. profile →
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol

2002 624 citations Tim C. Kirkham, Claire Williams et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Filomena Fezza Italy	43	6.1k	3.0k	1.3k	1.2k	1.2k	80	7.8k
Isabel Matias France	43	5.8k 1.0×	2.1k 0.7×	1.8k 1.3×	1.1k 0.9×	2.0k 1.6×	75	7.7k
Stefania Petrosino Italy	63	7.8k 1.3×	3.0k 1.0×	2.3k 1.8×	1.4k 1.1×	1.9k 1.5×	113	10.7k
Ruth A. Ross United Kingdom	45	7.9k 1.3×	4.5k 1.5×	1.1k 0.8×	1.5k 1.2×	1.0k 0.8×	111	9.8k
Aviva Breuer Israel	28	7.0k 1.1×	3.5k 1.2×	729 0.6×	1.4k 1.2×	867 0.7×	38	7.9k
Silvana Gaetani Italy	38	3.8k 0.6×	1.8k 0.6×	1.5k 1.2×	754 0.6×	1.1k 0.9×	80	6.9k
Takayuki Sugiura Japan	51	6.5k 1.1×	3.0k 1.0×	1.2k 1.0×	1.5k 1.2×	1.4k 1.1×	130	10.2k
Lesley Stevenson United Kingdom	17	5.9k 1.0×	3.3k 1.1×	568 0.4×	1.1k 0.9×	671 0.6×	30	6.7k
Monica Bari Italy	49	4.4k 0.7×	2.2k 0.7×	866 0.7×	774 0.6×	668 0.5×	104	6.1k
Judith Harvey‐White United States	38	4.1k 0.7×	1.8k 0.6×	1.6k 1.2×	830 0.7×	1.9k 1.6×	66	7.3k
William A. Devane United States	16	7.7k 1.3×	4.4k 1.5×	627 0.5×	1.6k 1.3×	801 0.7×	22	8.4k

Countries citing papers authored by Filomena Fezza

Since Specialization

Citations

This map shows the geographic impact of Filomena Fezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filomena Fezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filomena Fezza more than expected).

Fields of papers citing papers by Filomena Fezza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filomena Fezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filomena Fezza. The network helps show where Filomena Fezza may publish in the future.

Co-authorship network of co-authors of Filomena Fezza

This figure shows the co-authorship network connecting the top 25 collaborators of Filomena Fezza. A scholar is included among the top collaborators of Filomena Fezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filomena Fezza. Filomena Fezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maccarrone, Mauro, et al.. (2023). Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals. 16(12). 1678–1678. 2 indexed citations

Dainese, Enrico, Sergio Oddi, Annalaura Sabatucci, et al.. (2020). Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme. Scientific Reports. 10(1). 5903–5903. 2 indexed citations

Dainese, Enrico, Sergio Oddi, Annalaura Sabatucci, et al.. (2020). The endocannabinoid hydrolase FAAH is an allosteric enzyme. Scientific Reports. 10(1). 2292–2292. 30 indexed citations

Oddi, Sergio, Tomasz Maciej Stępniewski, Antonio Totaro, et al.. (2017). Palmitoylation of cysteine 415 of CB 1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(5). 523–532. 25 indexed citations

Verrottı, Alberto, et al.. (2016). Plant-Derived and Endogenous Cannabinoids in Epilepsy. Clinical Drug Investigation. 36(5). 331–340. 15 indexed citations

Madeo, Graziella, Tommaso Schirinzi, Marta Maltese, et al.. (2015). Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice. Neuropharmacology. 101. 460–470. 15 indexed citations

Chiurchiù, Valerio, Mirko Lanuti, Giuseppina Catanzaro, et al.. (2014). Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. Atherosclerosis. 233(1). 55–63. 61 indexed citations

Butini, Stefania, Sandra Gemma, Margherita Brindisi, et al.. (2012). Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. Bioorganic & Medicinal Chemistry Letters. 23(2). 492–495. 11 indexed citations

Oddi, Sergio, Enrico Dainese, Filomena Fezza, et al.. (2011). Functional characterization of putative cholesterol binding sequence (CRAC) in human type‐1 cannabinoid receptor. Journal of Neurochemistry. 116(5). 858–865. 82 indexed citations

10.

Pisani, Valerio, Vincenzo Moschella, Monica Bari, et al.. (2010). Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. Movement Disorders. 25(7). 920–924. 59 indexed citations

11.

Massi, Paola, Marta Valenti, Angelo Vaccani, et al.. (2007). 5‐Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non‐psychoactive cannabinoid. Journal of Neurochemistry. 104(4). 1091–1100. 113 indexed citations

12.

Centonze, Diego, Monica Bari, Silvia Rossi, et al.. (2007). The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain. 130(10). 2543–2553. 174 indexed citations

13.

Bari, Monica, Filomena Fezza, Sergio Oddi, et al.. (2006). Effect of Lipid Rafts on Cb2 Receptor Signaling and 2-Arachidonoyl-Glycerol Metabolism in Human Immune Cells. The Journal of Immunology. 177(8). 4971–4980. 57 indexed citations

14.

Gasperi, Valeria, et al.. (2005). Further Insights into the Regulation of Human FAAH by Progesterone and Leptin. NeuroToxicology. 26(5). 811–817. 17 indexed citations

15.

Matias, Isabel, Vincenzo Di Marzo, Tiziana Bisogno, et al.. (2004). STUDIES ON THE IN VITRO PHARMACOLOGY AND METABOLISM OF PROSTAGLANDIN–ETHANOLAMIDES (PROSTAMIDES) IN THE FELINE IRIS. Investigative Ophthalmology & Visual Science. 45(13). 1036–1036. 1 indexed citations

16.

Fezza, Filomena, et al.. (2004). Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. Analytical Biochemistry. 339(1). 113–120. 43 indexed citations

17.

González, Sara, Marta Valenti, Rosario de Miguel, et al.. (2004). Changes in endocannabinoid contents in reward‐related brain regions of alcohol‐exposed rats, and their possible relevance to alcohol relapse. British Journal of Pharmacology. 143(4). 455–464. 64 indexed citations

18.

Marzo, Vincenzo Di, Luciano De Petrocellis, Filomena Fezza, Alessia Ligresti, & Tiziana Bisogno. (2002). Anandamide receptors. Prostaglandins Leukotrienes and Essential Fatty Acids. 66(2-3). 377–391. 205 indexed citations

19.

Kirkham, Tim C., Claire Williams, Filomena Fezza, & Vincenzo Di Marzo. (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol. British Journal of Pharmacology. 136(4). 550–557. 624 indexed citations breakdown →

20.

Fezza, Filomena, Tiziana Bisogno, Alberto Minassi, et al.. (2002). Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Letters. 513(2-3). 294–298. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact